Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2002
10/10/2002US20020147997 Animal model for use in the diagnosis, prevention and treatment of cancer
10/10/2002US20020147332 Novel nucleoside and oligonucleotide analogues
10/10/2002US20020147329 Method of modulating tissue growth using Frzb protein
10/10/2002US20020147327 Glucocorticoid receptor protein for use in the treatment of arthritis and asthma
10/10/2002US20020147309 Human N-type calcium channel isoform and uses thereof
10/10/2002US20020147172 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
10/10/2002US20020147170 Constitutively active, hypersensitive, and nonfunctional recepors as novel therapeutic agents
10/10/2002US20020147162 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG)
10/10/2002US20020147161 Novel antisense inhibition of rad51
10/10/2002US20020146830 Methods and compositions for delivery of pharmaceutical agents
10/10/2002US20020146823 Propagating mesenchymal stem cells; obtain cells, incubate in preferentially generated propagation mixture, recover cells
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146802 Methods for producing and purifying recombinant alpha-L-iduronidase
10/10/2002US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders
10/10/2002US20020146796 Thymidine kinase mutant for use as tool in killing preferential cells; for use in gene therapy
10/10/2002US20020146795 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto
10/10/2002US20020146770 RAS proteins
10/10/2002US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002US20020146767 Human EMR1-like G protein-coupled receptor
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146751 fabF
10/10/2002US20020146719 Diagnosing narcolepsy in humans; obtain nucleotide sequences, detect mutation, presence of mutation indicates narcolepsy
10/10/2002US20020146708 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer
10/10/2002US20020146693 Isolation and identification of secreted proteins
10/10/2002US20020146683 Modified hiv env polypeptides
10/10/2002US20020146449 Compositions and methods for the targeted delivery of agents to treat liver cancer
10/10/2002US20020146432 Porcine circoviruses, vaccines and diagnostic reagents
10/10/2002US20020146423 Protective helicobacter antigens
10/10/2002US20020146421 Diagnosis and treatment of malignant neoplasms
10/10/2002US20020146408 Human haemopoietic maturation factor
10/10/2002US20020146396 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
10/10/2002US20020146395 Methods of inducing nervous tissue regeneration
10/10/2002US20020146392 Helper dependent adenovirus vectors based on site-specific recombinases
10/10/2002US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
10/10/2002DE10116594A1 Künstliche Chromosomen, die EHV-Sequenzen umfassen Include artificial chromosomes EHV sequences
10/10/2002DE10115073A1 Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren Use of inhibitors of IKK-ß and methods for finding such inhibitors
10/10/2002DE10112851C1 Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen Semi-allogeneic anti-tumor vaccine with HLA haplo-identical antigen presenting cells
10/10/2002DE10108412A1 Ocular pigment epithelial cells, useful for treating e.g. macular degeneration by implantation, are transformed with large-capacity adenoviral vector
10/10/2002CA2455915A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002CA2443324A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002CA2443179A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002CA2443176A1 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
10/10/2002CA2443045A1 Mucin peptide with immunoenhancing properties
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442619A1 Cancer-testis antigens
10/10/2002CA2442149A1 Viral vectors
10/10/2002CA2441654A1 Cytoskeleton-associated proteins
10/10/2002CA2441084A1 Improved conditionally replicating vectors for inhibiting viral infections
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2002EP1247862A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12)
10/09/2002EP1247530A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12)
10/09/2002EP1246946A2 Compositions and methods for the discovery and selection of biological information
10/09/2002EP1246935A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
10/09/2002EP1246931A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles
10/09/2002EP1246930A1 Replication incompetent herpes virus vectors
10/09/2002EP1246920A2 Prevention of affections associated with porcine circovirus-2
10/09/2002EP1246917A2 Human stra6 polypeptides
10/09/2002EP1246905A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use
10/09/2002EP1246902A2 Cell line for preparing and producing ovine adenovirus vectors
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002EP1246843A1 Novel fgf homolog zfgf12
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246841A1 Transcription factors containing two potential dna binding motifs
10/09/2002EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002EP1246649A1 Intravascular delivery of nucleic acid
10/09/2002EP1246642A2 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
10/09/2002EP1246532A2 Delivery of single stranded dna for expression
10/09/2002EP0880360B1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
10/09/2002EP0804562B1 Connective tissue growth factor-2
10/09/2002EP0743982B1 Immortalized human fetal osteoblastic cells
10/09/2002EP0625206B1 Human epidermal gene promoter
10/09/2002CN1373805A Antigenic meningococcal peptides
10/09/2002CN1373804A Conditional immortalisation of cells
10/09/2002CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002CN1373768A Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use
10/09/2002CN1092045C Vesicular complexes and methods of making and using same
10/08/2002US6462170 UPAR mimicking peptide
10/08/2002US6461867 Synthetic antigen presenting matrix
10/08/2002US6461851 High expression modules containing two or more tandem copies of a methioninase encoding sequence
10/08/2002US6461848 Degrades heparin sulfate preventing deposits of beta-amyloid senile plaques
10/08/2002US6461641 Adding to bioactive agent polymeric vehicle which gels or solidifies at time of or shortly after injection and has consistency and density to displace cells and to retain bioactive agent at injection site, thereby enhancing delivery
10/08/2002US6461617 Recombinant toxin fragments
10/08/2002US6461609 Recombinant α-galactosidase a therapy for Fabry disease
10/08/2002US6461606 Materials and methods for gene therapy
10/08/2002CA2231046C Human protein kinases hyak3
10/03/2002WO2002077281A1 Method of detecting nucleic acid relating to disease
10/03/2002WO2002077267A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002WO2002077236A2 Compositions and methods relating to lung specific genes and proteins
10/03/2002WO2002077228A1 Gene involved in v(d)j recombination and/or dna repair
10/03/2002WO2002077221A1 Packaging cell lines for the continuous production of alphavirus vectors
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077194A2 Polymer synthesis
10/03/2002WO2002077180A2 Novel nucleic acids and polypeptides
10/03/2002WO2002077156A2 Protection-of-telomere-1 (pot-1) protein and encoding polynucleotides
1 ... 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 ... 870